文献速递免疫规划传染病防控与疫情报告

巴西长期使用10价肺炎球菌结合疫苗后儿童肺炎球菌携带率、荚膜型、抗菌药物耐药性及相关危险因素

Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil.
PubMed 文献 · Vaccine · 2023-04-13

2019年9月至12月在巴西尼泰罗伊市开展横断面研究,招募430名6岁以下儿童,调查长期使用PCV10后肺炎球菌携带情况。携带率为17.4%,PCV10血清型仅占5.3%,青霉素非敏感菌占37.3%,多重耐药菌占22.6%且与血清型6C/D强相关。作者认为改用PCV13可使红霉素耐药菌和青霉素非敏感菌比例分别至少降低14%和18%。

要点

  • 430名6岁以下儿童中75名(17.4%)携带肺炎球菌,PCV10血清型仅占5.3%。
  • 青霉素非敏感肺炎球菌占37.3%,多重耐药菌占22.6%,与血清型6C/D强相关。
  • 作者认为改用PCV13可使红霉素耐药菌和青霉素非敏感菌比例分别至少降低14%和18%。

核心结论

  • 长期普遍使用PCV10几乎消除了PCV10血清型的携带,但多重耐药菌的高频率(尤其与血清型6C/D相关)仍值得关注。
  • 作者认为将PCV10替换为PCV13应能使红霉素耐药菌和青霉素非敏感菌的比例分别至少降低14%和18%。

研究设计与样本

  • 2019年9月至12月在巴西尼泰罗伊市开展横断面研究,招募6岁以下儿童。
  • 采用纸片扩散法检测抗菌药物敏感性,用E-test®测定对β-内酰胺类和大环内酯类的最低抑菌浓度(MIC)。
  • 采用多重PCR推断荚膜型,用逻辑回归预测肺炎球菌携带的危险因素。

主要发现

  • 430名儿童中75名(17.4%)为肺炎球菌携带者。
  • 最常见的荚膜型为6C/D(14.7%)、11A/D(13.3%)和23B(9.3%),PCV10血清型占5.3%。
  • 所有分离株对左氧氟沙星、利奈唑胺、利福平和万古霉素敏感。
  • 青霉素非敏感肺炎球菌(PNSP)占37.3%,对青霉素和头孢曲松的MIC范围分别为0.12至4.0 μg/ml和0.064至4.0 μg/ml。
  • 19株(25.3%)红霉素耐药(ERY-R)分离株(大环内酯类MIC为6至>256 μg/ml)中,多数为cMLSB表型(84.2%)并携带erm(B)基因(73.7%);检出17株(22.6%)多重耐药(MDR)分离株,与血清型6C/D强相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced for childhood vaccination in Brazil's National Immunization Program in 2010. After nine years of PCV10 use, we investigated the carriage prevalence, capsular types, antimicrobial resistance and risk factors among children living in Niterói city, RJ, Brazil. METHODS: Between September and December 2019, we conducted a cross-sectional study and recruited children under 6 years of age. Antimicrobial susceptibility was evaluated by the disk-diffusion method and MICs to beta-lactams and macrolides were determined by E-test®. Capsular types were deduced by multiplex PCR. Logistic regression was used to predict risk factors for pneumococcal carriage. RESULTS: Seventy-five (17.4%) of the 430 children were pneumococcal carriers. The most frequent capsular types were 6C/D (14.7%), 11A/D (13.3%), and 23B (9.3%). PCV10 serotypes represented 5.3%. All isolates were susceptible to levofloxacin, linezolid, rifampicin, and vancomycin. Penicillin non-susceptible pneumococci (PNSP) made up 37.3%, with penicillin and ceftriaxone MICs ranging from 0.12 to 4.0 μg/ml and 0.064-4.0 μg/ml, respectively. Of the 19 (25.3%) erythromycin-resistant (ERY-R) isolates (macrolide MICs of 6 to >256 μg/ml), most had the cMLSB phenotype (84.2%) and carried the erm(B) gene (73.7%). We detected 17 (22.6%) multidrug-resistant (MDR) isolates, strongly associated with serotype 6C/D. Presence of any symptoms, chronic diseases, childcare center attendance, living with young siblings, slum residence, and unstable income were predictors of pneumococcal carriage. CONCLUSIONS: Long-term universal childhood use of PCV10 has nearly eliminated carriage with PCV10 serotypes, but the high frequency of MDR isolates, especially associated with serotype 6C/D, remains a concern. Replacing PCV10 with PCV13 should reduce the proportion of ERY-R isolates and PNSP by at least 14% and 18%, respectively.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fortuna LBDP, Miranda FM, Antunes IMF, et al. Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil. Vaccine. 2023. PMID: 37061371. doi:10.1016/j.vaccine.2023.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。